Source document
Loading document…
KPIsSections1
Sections in this filing
Changes / Accountants
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated August 11, 2026 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. Date: August 11, 2026 By: /s/ Pedro J. Beltran Name: Pedro J. Beltran, Ph.D. Title: Chief Executive Officer